These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. mRNA-based therapeutics--developing a new class of drugs. Sahin U; Karikó K; Türeci Ö Nat Rev Drug Discov; 2014 Oct; 13(10):759-80. PubMed ID: 25233993 [TBL] [Abstract][Full Text] [Related]
6. mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases. Maruggi G; Zhang C; Li J; Ulmer JB; Yu D Mol Ther; 2019 Apr; 27(4):757-772. PubMed ID: 30803823 [TBL] [Abstract][Full Text] [Related]
8. Nanoscale platforms for messenger RNA delivery. Li B; Zhang X; Dong Y Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Mar; 11(2):e1530. PubMed ID: 29726120 [TBL] [Abstract][Full Text] [Related]
9. Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery. Kowalski PS; Rudra A; Miao L; Anderson DG Mol Ther; 2019 Apr; 27(4):710-728. PubMed ID: 30846391 [TBL] [Abstract][Full Text] [Related]
10. Nanoparticles for nucleic acid delivery: Applications in cancer immunotherapy. Mukalel AJ; Riley RS; Zhang R; Mitchell MJ Cancer Lett; 2019 Aug; 458():102-112. PubMed ID: 31100411 [TBL] [Abstract][Full Text] [Related]
11. Path towards mRNA delivery for cancer immunotherapy from bench to bedside. Chen W; Zhu Y; He J; Sun X Theranostics; 2024; 14(1):96-115. PubMed ID: 38164145 [TBL] [Abstract][Full Text] [Related]
13. mRNA as gene therapeutic: how to control protein expression. Tavernier G; Andries O; Demeester J; Sanders NN; De Smedt SC; Rejman J J Control Release; 2011 Mar; 150(3):238-47. PubMed ID: 20970469 [TBL] [Abstract][Full Text] [Related]
14. Advances in targeted delivery of mRNA into immune cells for enhanced cancer therapy. Huang L; Huang Z; Zhang Y; Lin C; Zhao Z; Li R; Saw PE; Xu X Theranostics; 2024; 14(14):5528-5550. PubMed ID: 39310113 [TBL] [Abstract][Full Text] [Related]